Pharma companies must balance HCP access and MHRA/ABPI compliance by preventing public search indexing of promotional ...

Almirall has announced that it will be hosting the 16th edition of its Skin Academy, a conference that encourages ...

ABPI's recent update permits QR codes in printed pharmaceutical materials for prescribing information. By ensuring visibility ...

As we approach 2025, healthcare and life sciences SMEs face an increasingly digital world. A seamless, mobile-friendly ...

Roche and Oxford BioTherapeutics (OBT) have entered into a partnership worth over $1bn to discover new antibody-based ...

Life sciences digital agency Genetic Digital has launched Pi 360, a cutting-edge web application designed to help ...

It is becoming an essential factor not only in the successful integration of medicines into clinical practice but also in ...

Johnson & Johnson’s (J&J) Tremfya (guselkumab) has been approved by the US Food and Drug Administration (FDA) to treat adults ...

Sanofi has announced that it will be broadening its immunology pipeline by acquiring Dren Bio’s phase 1 CD20-directed ...

AstraZeneca (AZ) has announced that its immunotherapy Imfinzi (durvalumab) has been approved by the European Commission (EC) ...

For example, developing a drug nowadays takes eight to ten years and costs over $2bn, yet less than 10% of clinical ...

AbbVie’s Elahere (mirvetuximab soravtansine-gynx) has demonstrated consistent survival benefits in a subset of ovarian cancer ...